ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis

Affiliations

• ¹ Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
• ² Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.
• ³ Department of Clinical Research, University c/o University Hospital of Basel, Basel, Switzerland.
• ⁴ Department of Dermatology, University Hospital of Bern, Bern, Switzerland.
• ⁵ Department of Dermatology, University Hospital of Lausanne, Lausanne, Switzerland.
• ⁶ Department of Dermatology, Plaza Klinik, Uster, Switzerland.
• ⁷ Faculty of Medicine, University of Zurich, Zurich, Switzerland.
• ⁸ Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland.